Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 1200 mg / day) in a Q.I.D. regimen

David Chadwick, T A Betts, Hugh G Boddie, Pamela Crawford, P Lindstrom, P K Newman, Imran Soryal, S Wroe, T A H Holdich

Seizure · 2002 · 19 citations · 6 references

DOIFull text

Open access

Concepts

References

6